• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    DCAT Week ’19

    Temperature-Controlled Logistics

    Reducing Pill Burden

    Nasal Drug Delivery

    AI in Pharma: Transforming Data into Drugs
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    AGC, Calypso Form Devt./Mfg. Deal

    Quanticate Appoints SVP of Project Delivery

    Alkermes, Clovis Form Cancer Research Collaboration

    APC Expands to U.S. with Opening of MA Facility

    Evotec & HZI Parnter for Novel Antibiotics
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    ACG Capsules Expands in Brazil

    AGC, Calypso Form Devt./Mfg. Deal

    APC Expands to U.S. with Opening of MA Facility

    Catalent Enters Clinical Supply Partnership with Adial

    Catalent Receives P&G Award
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    ACG Capsules Expands in Brazil

    Catalent Receives P&G Award

    GS1 Delivers Lightweight Messaging Standard For Verification of Product Identifiers

    Pelican BioThermal Opens New Network Location

    Reed-Lane Facility Tour
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Quanticate Appoints SVP of Project Delivery

    Alkermes, Clovis Form Cancer Research Collaboration

    APC Expands to U.S. with Opening of MA Facility

    Evotec & HZI Parnter for Novel Antibiotics

    Pii Inks Devt. Deal with Nemus
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Former FDA Senior Executives Join PAREXEL

    Top Global Pharma Company to Implement ValGenesis' VLMS

    WCG, Prudentia Enter Pharmacovigilance Alliance

    ValGenesis VLMS Chosen to Digitize Validation Process

    Serialization Compliance: Understanding the Challenges
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Baxter BioPharma Solutions

    Ajinomoto Bio-Pharma Services

    Ascendia Pharmaceuticals

    Aphena Pharma Solutions, Inc.

    Reed-Lane, Inc.
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Federal Equipment Company

    Baxter BioPharma Solutions

    Emergent BioSolutions, Inc.

    Aphena Pharma Solutions, Inc.

    Ascendia Pharmaceuticals
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    VIDEO: Vetter Appoints BD Manager for New South Korea Office

    Will support development, manufacturing and packaging of injectable drugs in the region

    Related CONTENT
    • PAREXEL, Osaka Cancer Institute Form Clinical Alliance in Japan
    • Fighting Back!
    • Vetter Breaks Ground for New Ravensburg Building
    • 2017 Contracting & Outsourcing Conference Wrap up
    • Vetter Expands Secondary Packaging Capacities
    02.02.18


    Vetter’s senior management representatives presented the company’s service portfolio along with its growth strategy for South Korea and the Asia Pacific (APAC) region at its new branch office in Songdo, South Korea. Mr. Michael Yi will manage the office as business development manager for Vetter Pharma International GmbH, South Korea. Mr. Yi, who is based in Songdo, has pharmaceutical experience having held business development roles at several companies. He reports to Ms. Chervee Ho, director key account management Asia Pacific.

    The region represents a growing market with a regulatory environment conducive to the industry. South Korea has invested in the pharmaceutical market supporting campaigns in R&D that contribute to innovative healthcare products. With its branch office, Vetter will support its existing South Korean business as well as that of new local and global customers, to help them meet development, manufacturing and packaging requirements for their injectable drugs.

    “As a leading contract and development manufacturing organization in prefilled drug delivery systems with a vast amount of experience in business development, we are well aware that being physically close to our customers and their ongoing projects is one of the keys to good client relationships,” said Vetter managing director Peter Soelkner. “Our event today acts as an additional signal of our strategy to build on our local presence and activities in this market,” highlights Oskar Gold, Vetter’s Senior Vice President Key Account Management, Marketing/Corporate Communications and Customer Project Management.
     
    “Vetter’s entry into the Korean pharmaceutical market represents an important recognition of the progress our nation has made in this segment,” said Javier Camposana, Celltrion’s managing
    director for Drug Product. “South Korean companies such as ours are in need of the services Vetter offers, to help us bring our innovative products to local and global markets. With its long history of qualitative resources, combined with its state-of-the art technology, Vetter can support us in competing on a level playing field and achieving our goals on a global scale. We wish Vetter a successful future in Korea.”
     
    Related Searches
    • Manufacturing
    • Drug Delivery
    • packaging
    • Pharma
    Suggested For You
    Contracting And Outsourcing Exhibitor List Contracting And Outsourcing Exhibitor List
    Softbox Acquires TP3 Global Softbox Acquires TP3 Global
    Pfizer CentreOne Contract Manufacturing Pfizer CentreOne Contract Manufacturing
    Vetter Receives Corporate Health Award Vetter Receives Corporate Health Award
    Basilea Extends Cresemba License Agreement with Pfizer Basilea Extends Cresemba License Agreement with Pfizer
    Vetter Expands Secondary Packaging Capacities Vetter Expands Secondary Packaging Capacities
    Vetter Expands Asia-Pac Footprint Vetter Expands Asia-Pac Footprint
    Contract Packaging Trends Roundtable Contract Packaging Trends Roundtable
    Vetter Expands Secondary Packaging Capacities Vetter Expands Secondary Packaging Capacities
    2017 Contracting & Outsourcing Conference Wrap up 2017 Contracting & Outsourcing Conference Wrap up
    Vetter Breaks Ground for New Ravensburg Building Vetter Breaks Ground for New Ravensburg Building
    Fighting Back! Fighting Back!
    PAREXEL, Osaka Cancer Institute Form Clinical Alliance in Japan PAREXEL, Osaka Cancer Institute Form Clinical Alliance in Japan

    Related Breaking News

    • Breaking News | Collaborations & Alliances | Drug Development | Industry News
      Pii Inks Devt. Deal with Nemus

      Pii Inks Devt. Deal with Nemus

      CDMO to develop dosage formulation for human dosing with NB1111 for glaucoma
      02.20.19

    • Bio News | Collaborations & Alliances | Drug Development | Industry News | Laboratory Testing | R&D
      Evotec & HZI Parnter for Novel Antibiotics

      Evotec & HZI Parnter for Novel Antibiotics

      Research activities will initially be focused on the optimization of cystobactamids
      02.20.19

    • Breaking News | Clinical Trials | Collaborations & Alliances | Drug Development | Industry News

      Gliknik Receives $15M Milestone from Pfizer

      Follows start of Phase 1 trial for Pfizer candidate PF-06755347
      02.20.19


    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      PPD & HLT Enter Development Agreement

      PPD & HLT Enter Development Agreement

      To create data science-driven clinical research solutions in China with the goal of enhancing global drug development
      02.20.19

    • Breaking News | Drug Development | Industry News
      Nestlé Health Licenses Codexis’ CDX-6114

      Nestlé Health Licenses Codexis’ CDX-6114

      Novel, oral enzyme for phenylketonuria is Codexis’ first internally developed biotherapeutic candidate
      02.19.19

    • Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
      SK, Arvelle Sign $530M Deal for Antiepileptic Drug

      SK, Arvelle Sign $530M Deal for Antiepileptic Drug

      Mark Altmeyer named president and chief executive of Arvelle
      02.15.19


    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
      Passage Bio Officially Launches

      Passage Bio Officially Launches

      With $115.5M Series A, to develop AAV-delivered therapeutics to treat rare monogenic CNS diseases
      02.15.19

    • Bio News | Collaborations & Alliances | Drug Development | Industry News | Methods Development | R&D
      Axovant Announces Formation of Arvelle Therapeutics

      Axovant Announces Formation of Arvelle Therapeutics

      Along with the strategic transition of legacy small molecule team into the newly formed company
      02.15.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      AbCellera & Novartis Announce Collaboration

      AbCellera & Novartis Announce Collaboration

      AbCellera to apply technology to advance programs on up to ten targets elected by Novartis
      02.15.19


    • Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      NeoTX, MedImmune Announce Clinical Collaboration

      NeoTX, MedImmune Announce Clinical Collaboration

      To support Phase 1b/2 studies investigating ANYARA in combination with AstraZeneca's IMFINZI
      02.11.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      Eton & Sintetica Enter Supply Agreement

      Eton & Sintetica Enter Supply Agreement

      To obtain U.S. marketing rights to two high-volume, near-term product launch candidates.
      02.11.19

    • Bio News | Breaking News | Collaborations & Alliances | Drug Development | Industry News
      3SBio, Verseau Establish Immuno-Oncology Devt. Collaboration

      3SBio, Verseau Establish Immuno-Oncology Devt. Collaboration

      3SBio will fund and conduct antibody development and GMP manufacturing
      02.11.19

    • Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
      MedPharm & Palvella Expand Partnership

      MedPharm & Palvella Expand Partnership

      For developing a new treatment for the debilitating rare disease, pachyonychia congenita
      02.11.19

    • Breaking News | Drug Development | Industry News
      IFM Therapeutics Launches Subsidiary

      IFM Therapeutics Launches Subsidiary

      IFM Due to advance cGAS/STING antagonists for serious inflammatory and autoimmune diseases
      02.11.19

    • Bio News | Collaborations & Alliances | Drug Development | Industry News | R&D
      Pathios, Sygnature Announce Partnership

      Pathios, Sygnature Announce Partnership

      For an integrated drug discovery program against a novel G Protein-Coupled Receptor (GPCR) target
      02.07.19

    Breaking News
    • AGC, Calypso Form Devt./Mfg. Deal
    • Quanticate Appoints SVP of Project Delivery
    • Alkermes, Clovis Form Cancer Research Collaboration
    • APC Expands to U.S. with Opening of MA Facility
    • Pii Inks Devt. Deal with Nemus
    View Breaking News >
    CURRENT ISSUE

    January/February 2019

    • DCAT Week ’19
    • Temperature-Controlled Logistics
    • Reducing Pill Burden
    • Nasal Drug Delivery
    • AI in Pharma: Transforming Data into Drugs
    • Digitization: Pharma 4.0
    • Serialization Compliance: Understanding the Challenges
    • FDA & Data Integrity
    • Rising Demand for Lyophilized Products
    • Future Trends in the CDMO Space
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • privacy policy
    • term and condition
    • about us
    • contact us

    follow us

    Subscribe

    magazines

    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image
    Image

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login